Sanofi is to buy Principia Biopharma for up to $3.68 billion ... give it full control of the brain-penetrant BTK inhibitor, SAR442168, making marketing more efficient and eliminating any royalty ...
Liver injuries also prompted the FDA to impose a partial clinical hold on Sanofi's BTK inhibitor tolebrutinib (SAR442168 ... of its $3.7 billion buyout of Principia Biopharma.
COLUMBIA, Mo – The Principia Boys Basketball team made history in Columbia on Thursday. Principia beat KIPP KC 76-56 in the Class 3 state championship, marking the first ever title in program ...
Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Principia's Paige Ivy (33) moves the ball around South Shelby's Charlie Roush (34) during a Class 3 state girls basketball ...
Both teams were dominant in their semifinal wins on Wednesday night. Principia beat Portageville 61-29, followed by Fair Grove's 55-22 victory over Lone Jack. Both were ranked as the top two teams ...
Get up-to-the-minute news sent straight to your device.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) (HERCULES). ClinicalTrials.gov. Updated February 3, ...